Beech Hill Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Beech Hill Advisors's XBI Position: Q1 2026 in Review
Beech Hill Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.4% in Q1 2026, selling an estimated $29.3K and leaving 5,160 shares worth $659K. The position accounts for 0.33% of the portfolio, ranked #71.
Beech Hill Advisors first reported a position in XBI in Q4 2023 and has held it in 10 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Beech Hill Advisors held 5,160 shares of State Street SPDR S&P Biotech ETF worth $659K as of Q1 2026.
- Beech Hill Advisors sold 235 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $29.3K.
- State Street SPDR S&P Biotech ETF made up 0.33% of Beech Hill Advisors's portfolio in Q1 2026, its #71 holding.
- Beech Hill Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 10 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Beech Hill Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.